Comparative effects of naproxen and aspirin on fever in children. 1979

T M Cashman, and R J Starns, and J Johnson, and J Oren

The antipyretic effect of single doses of naproxen, 2.5 mg/kg or 7.5 mg/kg, was compared to that of aspirin, 15 mg/kg, and of a placebo in a double-blind study. Febrile children, hospitalized overnight, were randomly assigned to one of the treatment or placebo groups, and their temperatures were recorded hourly. Naproxen, 7.5 mg/kg, was at least as effective as aspirin in onset of action and reduction of fever, and had a longer duration of action. Each of the three treatments had a significant effect as compared to that of the placebo. There was no difference in the total incidence of side effects among the four groups, but mild gastrointestinal complaints were more common among the patients in the high-dose naproxen group, whereas CNS complaints were more prevalent among the patients in the placebo group.

UI MeSH Term Description Entries
D009288 Naproxen An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout. Aleve,Anaprox,Methoxypropiocin,Naprosin,Naprosyn,Naproxen Sodium,Proxen,Sodium Naproxenate,Synflex,Naproxenate, Sodium,Sodium, Naproxen
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005334 Fever An abnormal elevation of body temperature, usually as a result of a pathologic process. Pyrexia,Fevers,Pyrexias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic

Related Publications

T M Cashman, and R J Starns, and J Johnson, and J Oren
January 1973, Scandinavian journal of rheumatology. Supplement,
T M Cashman, and R J Starns, and J Johnson, and J Oren
July 1980, Journal of clinical pharmacology,
T M Cashman, and R J Starns, and J Johnson, and J Oren
June 1987, Cancer,
T M Cashman, and R J Starns, and J Johnson, and J Oren
February 1981, Archives of internal medicine,
T M Cashman, and R J Starns, and J Johnson, and J Oren
April 1974, Clinical pharmacology and therapeutics,
T M Cashman, and R J Starns, and J Johnson, and J Oren
January 1976, Clinical pharmacology and therapeutics,
T M Cashman, and R J Starns, and J Johnson, and J Oren
November 1978, Pediatrics,
T M Cashman, and R J Starns, and J Johnson, and J Oren
February 1981, Archives of internal medicine,
T M Cashman, and R J Starns, and J Johnson, and J Oren
January 1984, Clinical and experimental hypertension. Part A, Theory and practice,
Copied contents to your clipboard!